Cascade of Care in the Management of Latent Tuberculosis Infection in the United States: A Lot to Improve and to Scale Up

Ann Am Thorac Soc. 2021 Oct;18(10):1620-1621. doi: 10.1513/AnnalsATS.202106-722ED.

Authors

John W Wilson¹, Dana G Kissner², Patricio Escalante³

Affiliations

¹ Division of Infectious Diseases and.
² Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan.
³ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota; and.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Antitubercular Agents / therapeutic use
Health Personnel
Humans
Latent Tuberculosis* / diagnosis
Latent Tuberculosis* / drug therapy
Latent Tuberculosis* / epidemiology
United States

Substances

Antitubercular Agents